Ikena Oncology down on missing Q3 revenue estimates

ImageneBio

09/11/2023 15:20

** Ikena Oncology's shares  IKNA.O  fall 51.5% to $2 -
biggest one-day pct. drop ever
    ** Drug developer reported revenue of $1.19 million,
compared with estimates of $2.55 mln -LSEG data
    ** Co's Q3 per share loss was 40 cents, which was lower than
estimates of 43 cents - LSEG
    ** 5 of 5 brokerages rate the stock "buy" or higher; their
median PT is $17
    ** Including session gains, stock had fallen ~20% YTD 

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))